Search Results

Filter
  • 1-10 of  44,658 results for ""Antigens, Surface""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Simultaneous targeting and monitoring of free antigen and in-situ membrane antigen in prostate cancer cells via an aggregation-induced emission-based bifunctional probe.

  • Authors : Wang L; School of Environmental and Chemical Engineering, Jiangsu University of Science and Technology, Zhenjiang, 212003, Jiangsu Province, PR China.; Zhuang Y

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/blood ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnosis ; Biosensing Techniques*/Biosensing Techniques*/Biosensing Techniques*/methods

  • Source: Biosensors & bioelectronics [Biosens Bioelectron] 2024 Nov 01; Vol. 263, pp. 116581. Date of Electronic Publication: 2024 Jul 26.Publisher: Elsevier Advanced Technology Country of Publication: England NLM ID: 9001289 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Expression of PSMA in Tumor-Associated Vasculature Predicts Poorer Survival in Patients With Hepatocellular Carcinoma and Is Likely Associated With PD-L1.

  • Authors : Li RX; High School Intern, Pittsford Mendon High School, Pittsford, NY, USA.; Hao Y

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/mortality ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: International journal of surgical pathology [Int J Surg Pathol] 2024 Oct; Vol. 32 (7), pp. 1248-1255. Date of Electronic Publication: 2024 Feb 06.Publisher: Sage Publications Country of Publication: United States NLM ID: 9314927 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy.

  • Authors : Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.; Morris MJ

Subjects: Radiopharmaceuticals*/Radiopharmaceuticals*/Radiopharmaceuticals*/therapeutic use ; Radiopharmaceuticals*/Radiopharmaceuticals*/Radiopharmaceuticals*/adverse effects ; Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/metabolism

  • Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Nov 01; Vol. 65 (11), pp. 1666-1671. Date of Electronic Publication: 2024 Nov 01.Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

PSMA and Sigma-1 receptor dual-targeted peptide mediates superior radionuclide imaging and therapy of prostate cancer.

  • Authors : Huangfu Z; Biomedical Polymers Laboratory, College of Chemistry, Chemical Engineering and Materials Science, and State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, People's Republic of China; College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, People's Republic of China.

Subjects: Receptors, sigma*/Receptors, sigma*/Receptors, sigma*/metabolism ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnostic imaging ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/radiotherapy

  • Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Nov; Vol. 375, pp. 767-775. Date of Electronic Publication: 2024 Oct 02.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin.

  • Authors : Kuzmanov A; Department of Urology, University Hospital Zürich, University of Zurich, Laboratory for Urologic Oncology and Stem Cell Therapy, Zurich, Switzerland.; Salemi S

Subjects: Dutasteride*/Dutasteride*/Dutasteride*/pharmacology ; Dutasteride*/Dutasteride*/Dutasteride*/therapeutic use ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/metabolism

  • Source: Neoplasia (New York, N.Y.) [Neoplasia] 2024 Nov; Vol. 57, pp. 101045. Date of Electronic Publication: 2024 Sep 05.Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Potential of PSMA for breast cancer in nuclear medicine: digital quantitative immunohistochemical analysis and implications for a theranostic approach.

  • Authors : Neviere Z; Department of Medical Oncology, Comprehensive Cancer Centre F. Baclesse, UNICANCER, Caen, France.; Blanc-Fournier C

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/therapy

  • Source: BMC cancer [BMC Cancer] 2024 Oct 29; Vol. 24 (1), pp. 1328. Date of Electronic Publication: 2024 Oct 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

Synthesis and Evaluation of 99m Tc-Labeled D Pro-Gly-Containing Tracers Targeting PSMA.

  • Authors : Li Z; Key Laboratory of Radiopharmaceuticals of the Ministry of Education, College of Chemistry, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing Normal University, Beijing 100875, P. R. China.; Jiang Y

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnostic imaging ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/metabolism ; Radiopharmaceuticals*/Radiopharmaceuticals*/Radiopharmaceuticals*/pharmacokinetics

  • Source: Molecular pharmaceutics [Mol Pharm] 2024 Oct 07; Vol. 21 (10), pp. 5305-5314. Date of Electronic Publication: 2024 Sep 19.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Intra-arterial administration of PSMA-targeted radiopharmaceuticals for brain tumors: is the era of interventional theranostics next?

  • Authors : Da Ros V; Diagnostic Imaging Unit, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.; Filippi L

Subjects: Antigens, Surface*/Antigens, Surface*/Antigens, Surface*/metabolism ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/therapy ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/diagnostic imaging

  • Source: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2024 Oct; Vol. 24 (10), pp. 925-929. Date of Electronic Publication: 2024 Aug 29.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Novel technetium-99m-labeled bivalent PSMA-targeting probe based on hydroxamamide chelate for diagnosis of prostate cancer.

  • Authors : Shimizu Y; Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29, Yoshida Shimoadachi-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan. .; Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, 54 Kawahara-Cho, Shogoin, Sakyo-Ku, Kyoto, 606-8507, Japan. .

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnostic imaging ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/metabolism ; Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/metabolism

  • Source: Annals of nuclear medicine [Ann Nucl Med] 2024 Oct; Vol. 38 (10), pp. 847-851. Date of Electronic Publication: 2024 Jul 08.Publisher: Springer Japan Country of Publication: Japan NLM ID: 8913398 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Should new organ involvement be included in Response Evaluation Criteria in PSMA Imaging?

  • Authors : Kaplan İ; Department of Nuclear Medicine, Gazi Yasargil Training and Research Hospital, 21070, Kayapınar, Diyarbakir, Turkey. .; Kömek H

Subjects: Positron Emission Tomography Computed Tomography* ; Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/metabolism ; Antigens, Surface*/Antigens, Surface*/Antigens, Surface*/metabolism

  • Source: Annals of nuclear medicine [Ann Nucl Med] 2024 Oct; Vol. 38 (10), pp. 825-834. Date of Electronic Publication: 2024 Jun 16.Publisher: Springer Japan Country of Publication: Japan NLM ID: 8913398 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  44,658 results for ""Antigens, Surface""